FDA

Updated ET, Sat ,

The shortened waiting period for boosters comes as data shows that two doses do not provide strong protection against symptomatic infection from omicron. ...
The Food and Drug Administration on Friday shortened the interval between the primary series of Moderna's COVID-19 vaccine and a booster dose to five months, as it looks to bolster protection against the fast-spreading omicron variant. ...
Former FDA Commissioner Scott Gottlieb reacts to six former health advisers to President Biden saying the administration needs to completely change it’s Covid strategy, telling MSNBC’s Stephanie Ruhle we need to treat it as “our new normal.”  ...
The judge's order comes after the FDA asked for 75 years to release data pertaining to the safety of Pfizer's coronavirus vaccine. ...

( )